Smartleaf Asset Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.76K Hold
436
﹤0.01% 2698
2026
Q1
$7.31K Sell
436
-1,207
-73% -$21.6K ﹤0.01% 2467
2025
Q4
$26.5K Buy
1,643
+214
+15% +$3.19K ﹤0.01% 1883
2025
Q3
$17.9K Sell
1,429
-257
-15% -$3.01K ﹤0.01% 1855
2025
Q2
$19.8K Buy
1,686
+339
+25% +$4.02K ﹤0.01% 1560
2025
Q1
$20.6K Sell
1,347
-690
-34% -$11.6K ﹤0.01% 1589
2024
Q4
$34.8K Buy
2,037
+1,293
+174% +$24.9K ﹤0.01% 1351
2024
Q3
$13.6K Buy
744
+11
+2% +$221 ﹤0.01% 1569
2024
Q2
$14.5K Buy
733
+685
+1,427% +$12.1K ﹤0.01% 1194
2024
Q1
$815 Buy
+48
New +$755 ﹤0.01% 1655

Other funds holding CLB

Smartleaf Asset Management's CLB Position: Q2 2026 in Review

Smartleaf Asset Management held its Core Laboratories (CLB) position steady in Q2 2026 at 436 shares worth $4.76K. The position accounts for ﹤0.01% of the portfolio, ranked #2698.

Smartleaf Asset Management first reported a position in CLB in Q1 2024 and has held it in 10 quarters since. The position peaked at $34.8K in Q4 2024. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Smartleaf Asset Management held 436 shares of Core Laboratories worth $4.76K as of Q2 2026.
  • Smartleaf Asset Management left its Core Laboratories share count unchanged in Q2 2026.
  • Core Laboratories made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2698 holding.
  • Smartleaf Asset Management first reported a position in Core Laboratories in Q1 2024 and has held it in 10 quarters since.
  • Smartleaf Asset Management's Core Laboratories position peaked at $34.8K in Q4 2024.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.